UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000009461
Receipt number R000011115
Scientific Title The study about the mechanism of action of omega-3 polyunsaturated fatty acids(EPA)
Date of disclosure of the study information 2012/12/03
Last modified on 2012/12/03 12:11:19

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The study about the mechanism of action of omega-3 polyunsaturated fatty acids(EPA)

Acronym

The study about the mechanism of action of omega-3 polyunsaturated fatty acids(EPA)

Scientific Title

The study about the mechanism of action of omega-3 polyunsaturated fatty acids(EPA)

Scientific Title:Acronym

The study about the mechanism of action of omega-3 polyunsaturated fatty acids(EPA)

Region

Japan


Condition

Condition

healthy adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

To analyze about genes expression with administration of EPA in healthy adults.

Basic objectives2

Others

Basic objectives -Others

pharmacogenomics

Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

The change of genes expression in peripheral leukocyte of healthy adults before and after EPA administration.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

4 weeks Administration of EPA (epadel, 1800mg/day) for healthy adults

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >=

Gender

Male and Female

Key inclusion criteria

Subjects are medical personnel belonging to the department of psychiatry,Tokushima university hospital or related organizations.

Key exclusion criteria

Persons on medications are excluded.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Tetsuro Ohmori

Organization

Institute of Health Biosciences,The University of Tokushima Graduate School

Division name

Department of Psychiatry

Zip code


Address

Kuramoto-cho 2-50-1,Tokushima city 770-8503

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

Institute of Health Biosciences,The University of Tokushima Graduate School

Division name

Department of Psychiatry

Zip code


Address


TEL

0886337130

Homepage URL


Email



Sponsor or person

Institute

Department of Psychiatry,Institute of Health Biosciences,The University of Tokushima Graduate School

Institute

Department

Personal name



Funding Source

Organization

Japan society for the promotion of science

Organization

Division

Category of Funding Organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2012 Year 12 Month 03 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2013 Year 01 Month 15 Day

Date of IRB


Anticipated trial start date

2013 Year 01 Month 10 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2012 Year 12 Month 03 Day

Last modified on

2012 Year 12 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000011115


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name